Safety evaluation of fixed-dose nivolumab in patients with gastric cancer.

Yusuke Iikura Takeshi AoyamaMakoto HiraideTakeru WakatsukiIzuma NakayamaMariko OguraAkira OokiDaisuke TakahariKeisho ChinKensei YamaguchiToshihiro Hama

Published in: Health science reports (2022)

This is the first report on the safety of nivolumab at 240 mg in Japanese patients.

Keyphrases